These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9364843)

  • 21. Enhanced erythropoietin secretion in hepatoblastoma cells in response to hypoxia.
    Ueno M; Seferynska I; Beckman B; Brookins J; Nakashima J; Fisher JW
    Am J Physiol; 1989 Oct; 257(4 Pt 1):C743-9. PubMed ID: 2552819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of low calcium levels on erythropoietin production by human renal carcinoma cells in culture.
    Nagakura K; Ueno M; Brookins J; Beckman BS; Fisher JW
    Am J Physiol; 1987 Dec; 253(6 Pt 1):C797-801. PubMed ID: 3425704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased secretion of erythropoietin in human renal carcinoma cells in response to atrial natriuretic factor.
    Ueno M; Rondon I; Beckman B; Brookins J; Nakashima J; Cole FE; Fisher JW
    Am J Physiol; 1990 Sep; 259(3 Pt 1):C427-31. PubMed ID: 2169194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of erythropoietin-like activity by human renal and hepatic carcinomas in cell culture.
    Okabe T; Urabe A; Kato T; Chiba S; Takaku F
    Cancer; 1985 May; 55(9):1918-23. PubMed ID: 4038914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression of erythropoietin in renal cell carcinoma.
    Noguchi Y; Goto T; Yufu Y; Uike N; Hasegawa Y; Fukuda T; Jimi A; Funakoshi A
    Intern Med; 1999 Dec; 38(12):991-4. PubMed ID: 10628941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of prostaglandins in hypoxia-stimulated erythropoietin production.
    Kurtz A; Jelkmann W; Pfeilschifter J; Bauer C
    Am J Physiol; 1985 Jul; 249(1 Pt 1):C3-8. PubMed ID: 2990227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of erythropoietin production in a hepatocellular carcinoma cell line.
    Nakashima J; Brookins J; Fisher JW
    J Lab Clin Med; 1992 Mar; 119(3):306-14. PubMed ID: 1311742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Increase in erythropoietin secretion mediated by adenosine A2 receptors].
    Nakashima J; Tazaki H; Fisher JW
    Hum Cell; 1993 Mar; 6(1):36-41. PubMed ID: 8393698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ultrastructural immunocytochemical studies on erythropoietin-producing cells in a human renal carcinoma grown in athymic nude mice and primary monolayer cultures].
    Hagiwara M
    Nihon Hinyokika Gakkai Zasshi; 1987 May; 78(5):834-43. PubMed ID: 3320435
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical significance of erythropoietin levels in renal carcinoma.
    Nseyo UO; Williams PD; Murphy GP
    Urology; 1986 Oct; 28(4):301-6. PubMed ID: 3765240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of erythropoietin-producing renal cell carcinoma with polycythemia].
    Okuyama M; Nishihara M; Hashimoto H; Kaneko S; Yachiku S
    Hinyokika Kiyo; 2002 Sep; 48(9):531-4. PubMed ID: 12402477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic modulation of erythropoietin production.
    Fisher JW
    Annu Rev Pharmacol Toxicol; 1988; 28():101-22. PubMed ID: 3289482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of erythropoietin-producing renal cancer].
    Ishibashi Y; Sakai N; Fukuoka H; Sakanishi S
    Hinyokika Kiyo; 1990 May; 36(5):577-80. PubMed ID: 2399859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and characterization of a human renal carcinoma cell line MRT-1, with special reference to the production of serine proteinase inhibitors.
    Muraoka K; Kataoka H; Nabeshima K; Seguchi K; Moriyama T; Osada Y; Koono M
    Hum Cell; 1995 Mar; 8(1):11-8. PubMed ID: 7669747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of erythropoietin-producing renal cell carcinoma with a skin metastasis].
    Furukawa A; Kanda K; Yokozeki H; Maebayashi K; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1992 Feb; 83(2):247-50. PubMed ID: 1556845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine A2 receptor modulation of erythropoietin secretion in hepatocellular carcinoma cells.
    Nakashima J; Brookins J; Ohigashi T; Fisher JW
    Life Sci; 1994; 54(2):109-17. PubMed ID: 8123156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Renal cell carcinoma producing erythrocytosis due to inappropriate production of erythropoietin].
    Villanueva-Gimeno MM; Vicario-Bermúdez JM; Fonseca-López Ch; Caballero-Castro JP; Zabala-López SI; Sánchez-Elipe MA; González-Gómez N
    Semergen; 2013; 39(5):282-4. PubMed ID: 23834980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.
    Stoyanoff TR; Rodríguez JP; Todaro JS; Espada JD; Colavita JP; Brandan NC; Torres AM; Aguirre MV
    Tumour Biol; 2016 Oct; 37(10):13581-13593. PubMed ID: 27468719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment and characterization of a renal cell carcinoma cell line (FU-UR-1) with the reciprocal ASPL-TFE3 fusion transcript.
    Ishiguro M; Iwasaki H; Ohjimi Y; Kaneko Y
    Oncol Rep; 2004 Jun; 11(6):1169-75. PubMed ID: 15138551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythropoietin production in human renal carcinoma cells passaged in nude mice and in tissue culture.
    Katsuoka Y; McGonigle R; Rege AB; Beckman B; Fisher JW
    Gan; 1983 Aug; 74(4):534-41. PubMed ID: 6628905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.